Author
Lorenzo Fornaro
Also Known As
Fornaro L, Fornaro, L., Fornaro, Lorenzo, L FORNARO, L Fornaro, L. Fornaro, L., Fornaro, LORENZO FORNARO, Lorenzo Fornaro, on behalf of the GICO group (Gruppo Italiano COlangiocarcinoma)
337
Publications
6.1K
Citations
34
H-Index
37
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 20 | 29 | 2.7K |
2 | Gastroenterology | 8 | 8 | 1.7K |
3 | Health Sciences | 5 | 5 | 107 |
4 | Hepatology | 1 | 1 | 23 |
5 | Immunology | 1 | 1 | 51 |
Lorenzo Fornaro
×
76
Publications
4.8K
Citations
31
H-Index
| Year | Citations | |
|---|---|---|
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial Kohei Shitara, Mustafa Özgüroğlu, Yung‐Jue Bang, Pembrolizumab Versus PaclitaxelGastrointestinal OncologyMedicineGastroenterologySurgery | 2018 | 1.3K |
2010 | 240 | |
2009 | 234 | |
2024 | 195 | |
2009 | 191 | |
2010 | 188 | |
2015 | 164 | |
2021 | 162 | |
2016 | 142 | |
2011 | 114 |
Page 1
Page 1